Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ospemifene
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved FDF
Sponsor : Plushcare
Deal Size : Undisclosed
Deal Type : Partnership
Details : The aim of this partnership is to provide Duchesnay USA's Osphena® (ospemifene) to women suffering from vaginal symptoms related to menopause, with the possibility of having this conversation with a healthcare provider in the comfort and privacy of the...
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Undisclosed
May 19, 2020
Lead Product(s) : Ospemifene
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Sponsor : Plushcare
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Ospemifene
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause
Details : Undisclosed
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
December 23, 2015
Lead Product(s) : Ospemifene
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ospemifene
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : QuatRx Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
April 26, 2012
Lead Product(s) : Ospemifene
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : QuatRx Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ospemifene
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : QuatRx Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
April 26, 2012
Lead Product(s) : Ospemifene
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : QuatRx Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable